Advances In Eyecare

In 2018, the RCO released new guidelines on screening for hydroxychloroquine and chloroquine retinopathy. This was in response to an increase in the use of the drugs, drugs that for a long time have been known to have significant ocular side effects. The new guidelines make specific recommendations on the techniques and timing of baseline and follow-up screening tests. To understand the importance of these drugs, dermatologist Dr Sharon Blackford provides a background summary on their clinical use. Following this, ophthalmologist Dr Tariq Aslam explains the new guidelines and how they will work in practice.